REQUEST A DEMO
Total
USD $0.00
Search more companies

Pure Clinical Sp. z o.o. (Poland)

Main Activities: Computer Systems Design and Related Services
Full name: Pure Clinical Sp. z o.o. Profile Updated: December 04, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Pure Clinical Sp. z o.o. is an enterprise in Poland, with the main office in Warsaw. It operates in the Computer Systems Design and Related Services sector. It was incorporated on September 16, 2021. From the latest financial highlights, Pure Clinical Sp. z o.o. reported a net sales revenue drop of 66.47% in 2024. Over the same period, its total assets decreased by 9.76%. The net profit margin of Pure Clinical Sp. z o.o. decreased by 57.73% in 2024.

Headquarters
Ul. Aleje Jerozolimskie 123A
Warsaw; Mazowieckie; Postal Code: 02-017

Contact Details: Purchase the Pure Clinical Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Pure Clinical Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Pure Clinical Sp. z o.o. report to view the information.
Incorporation Date:
September 16, 2021
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
95%
Subsidiaries
Pure Clinical Lab Network Sp. z o.o.
75%
Company Performance
Financial values in the chart are available after Pure Clinical Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-66.47%
Total operating revenue
-64.49%
Operating profit (EBIT)
-614.81%
EBITDA
-1146.12%
Net Profit (Loss) for the Period
-285.72%
Total Assets
-9.76%
Total Equity
-18.31%
Operating Profit Margin (ROS)
-68.8%
Net Profit Margin
-57.73%
Return on Equity (ROE)
-20.95%
Quick Ratio
-11.96%
Cash Ratio
-6.74%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?